|
Consumers survey results of for 2 quarter of 2024 in category Gynecology, urology, nephrology / The drug from vaginal candidiasis (thrush)
 The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year. |
 |
I quarter (january—march) |
 |
II quarter (april—june) |
 |
III quarter (july—september) |
 |
IV quarter (october—december) |
|
| 1. |
Дифлюзол (Arterium Corporation)
|
50.00% |
5 |
|
|
| 1. |
Кандид (Glenmark Farmaceuticals Limited)
|
50.00% |
5 |
|
|
| 3. |
Дифлюкан (Pfizer Inc.) |
25.00% |
2.50 |
|
|
| 3. |
Кандібене (ratiopharm)
|
25.00% |
2.50 |
|
|
| 3. |
Клотримазол (ORGANOSYN) |
25.00% |
2.50 |
|
|
| 3. |
Мікогель-КМП (Arterium Corporation)
|
25.00% |
2.50 |
|
|
| 3. |
Флуконазол-Дарниця (Darnitsa)
|
25.00% |
2.50 |
|
|
| –. |
Гінофорт (Gedeon Richter)
|
0.00% |
0 |
 |
| –. |
Кетодин (Сперко Україна)
|
0.00% |
0 |
|
|
| –. |
Клофан (Kusum Pharm)
|
0.00% |
0 |
|
|
| –. |
Ливарол (Nizhpharm)
|
0.00% |
0 |
|
|
| –. |
Мікогал (Teva)
|
0.00% |
0 |
|
|
| –. |
Мікомакс (Zentiva) |
0.00% |
0 |
|
|
| –. |
Мікосист (Gedeon Richter)
|
0.00% |
0 |
|
|
| –. |
Пімафуцин (Delta Medical)
|
0.00% |
0 |
|
|
| –. |
Флунол (Нобель Ілач) |
0.00% |
0 |
|
|
| –. |
Флуомизин (Delta Medical)
|
0.00% |
0 |
|
|
| –. |
Фуніт (Нобель Ілач) |
0.00% |
0 |
|
| |
The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.
